Position in MRK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$6,822,322
+$445,028 QoQ
Shares Held
53,092
+0.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#900
of 3,769 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GQG Partners LLC holds $855,412,874 across 8 Drug Manufacturers - General names. MRK ranks #4 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
1,921,614 | $483,554,946 | |
| 2 | NVS |
Novartis AG
|
2,151,131 | $337,125,250 | |
| 3 | AZN |
Astrazeneca PLC
|
45,569 | $8,640,793 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
53,092 | $6,822,322 | |
| 5 | JNJ |
Johnson & Johnson
|
25,158 | $6,389,377 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
96,264 | $5,546,731 | |
| 7 | SNY |
Sanofi
|
97,640 | $4,165,322 | |
| 8 | PFE |
Pfizer Inc
|
131,567 | $3,168,133 |
All Filings in MRK
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,822,322 | 53,092 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $6,377,294 | 53,016 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $5,632,357 | 53,509 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,456,599 | 53,099 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,511,724 | 56,995 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,558,192 | 50,782 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $5,763,174 | 57,933 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $103,388,430 | 910,430 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $7,191,789 | 58,092 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $6,391,526 | 48,439 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $4,024,146 | 36,912 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,868,861 | 37,580 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,336,356 | 37,580 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $3,998,136 | 37,580 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,724,702 | 33,571 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,891,134 | 33,571 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $384,195,759 | 4,214,059 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $716,624 | 8,734 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $631,743 | 8,243 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $402,739 | 5,362 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $558,932 | 7,187 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $460,073 | 5,968 | Shares | Sole | 2021-05-14 | |
| 2020-03-31 | $236,667 | 3,076 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||